Michael D. Green

17.6k total citations · 2 hit papers
168 papers, 6.7k citations indexed

About

Michael D. Green is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michael D. Green has authored 168 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 31 papers in Pulmonary and Respiratory Medicine and 31 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michael D. Green's work include Cancer Immunotherapy and Biomarkers (28 papers), Malaria Research and Control (19 papers) and Pharmaceutical Quality and Counterfeiting (17 papers). Michael D. Green is often cited by papers focused on Cancer Immunotherapy and Biomarkers (28 papers), Malaria Research and Control (19 papers) and Pharmaceutical Quality and Counterfeiting (17 papers). Michael D. Green collaborates with scholars based in United States, Australia and United Kingdom. Michael D. Green's co-authors include Robert L. Sutherland, Facundo M. Fernández, Paul N. Newton, Russell L. Basser, Hans‐Willem Snoeck, Sarah X.L. Huang, Roger R. Reddel, Melanie Mumau, Ya‐Wen Chen and Nicholas J. White and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Michael D. Green

157 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression

2018 449 citations Shuang Wei, Michael D. Green et al. profile →
Efficient generation of lung and airway epithelial cells from human pluripotent stem cells

2013 423 citations Michael D. Green, Hans‐Willem Snoeck et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael D. Green United States	39	1.8k	1.7k	1.4k	1.3k	911	168	6.7k
R. Kreienberg Germany	54	4.3k 2.4×	2.1k 1.2×	1.0k 0.8×	1.3k 1.0×	1.3k 1.4×	434	10.6k
Laura F. Hutchins United States	40	4.0k 2.2×	1.7k 1.0×	575 0.4×	1.7k 1.3×	672 0.7×	121	7.2k
Wei Zhang China	50	1.8k 1.0×	4.2k 2.4×	873 0.6×	918 0.7×	791 0.9×	373	10.4k
David B. Thomas United States	50	2.4k 1.3×	1.8k 1.0×	1.2k 0.9×	940 0.7×	947 1.0×	222	9.1k
Peter C. Adamson United States	59	2.7k 1.5×	3.5k 2.0×	2.2k 1.6×	2.2k 1.7×	652 0.7×	238	11.3k
Marsha E. Reichman United States	36	2.1k 1.2×	1.1k 0.7×	624 0.5×	898 0.7×	878 1.0×	65	7.7k
Jerry M. Collins United States	52	3.1k 1.7×	2.7k 1.6×	637 0.5×	1.3k 1.0×	893 1.0×	176	9.0k
William T. Barry United States	47	4.3k 2.4×	2.1k 1.3×	628 0.5×	1.6k 1.2×	550 0.6×	191	8.4k
Otis W. Brawley United States	34	5.1k 2.8×	2.3k 1.4×	895 0.7×	3.6k 2.7×	1.3k 1.4×	61	11.5k
Karen Messer United States	50	1.3k 0.7×	2.3k 1.3×	1000 0.7×	675 0.5×	489 0.5×	212	8.1k

Countries citing papers authored by Michael D. Green

Since Specialization

Citations

This map shows the geographic impact of Michael D. Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Green more than expected).

Fields of papers citing papers by Michael D. Green

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Green. The network helps show where Michael D. Green may publish in the future.

Co-authorship network of co-authors of Michael D. Green

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Green. A scholar is included among the top collaborators of Michael D. Green based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Green. Michael D. Green is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gonzalez, Richard, Will Jackson, Megan E.V. Caram, et al.. (2025). Rates of PSMA PET Staging and Positivity in Newly Diagnosed Prostate Cancer in a National Health Care System. Journal of Nuclear Medicine. 66(1). 75–83. 5 indexed citations

Bryant, Alex K., et al.. (2024). Effect of common medications on immune checkpoint inhibitor efficacy.. Journal of Clinical Oncology. 42(16_suppl). e14710–e14710. 1 indexed citations

Bryant, Alex K., Yuewei Lin, James M. Rae, et al.. (2024). Artificial intelligence to unlock real‐world evidence in clinical oncology: A primer on recent advances. Cancer Medicine. 13(12). e7253–e7253. 4 indexed citations

Jiang, Long, Weiwei Wang, Amanda K. Huber, et al.. (2024). Potentiating the radiation-induced type I interferon anti-tumoral immune response by ATM inhibition in pancreatic cancer. JCI Insight. 9(6). 7 indexed citations

Schipper, Matthew J., Lars G. Fritsche, Garth W. Strohbehn, et al.. (2024). Pan‐Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare System. Cancer Medicine. 13(21). e70379–e70379. 4 indexed citations

Chen, Wei‐Min, Oudai Hassan, Farzan Siddiqui, et al.. (2024). BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 163–163. 6 indexed citations

Zhao, Lili, Michael D. Green, Andrea Towlerton, et al.. (2024). Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer. Scientific Reports. 14(1). 345–345. 10 indexed citations

Edwards, Donna M., K. Nathan Sankar, Matthew J. Schipper, et al.. (2023). Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 118(4). 963–970. 8 indexed citations

Bryant, Alex K., K. Nathan Sankar, Lili Zhao, et al.. (2022). De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer. European Journal of Cancer. 171. 55–63. 17 indexed citations

10.

Zhao, Kailiang, Qiang Zhang, Xueting Lang, et al.. (2021). Cytidine Deaminase APOBEC3A Regulates PD-L1 Expression in Cancer Cells in a JNK/c-JUN-Dependent Manner. Molecular Cancer Research. 19(9). 1571–1582. 10 indexed citations

11.

Bryant, Alex K., K. Nathan Sankar, Garth W. Strohbehn, et al.. (2021). Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer. Lung Cancer. 163. 35–41. 22 indexed citations

12.

Zhang, Qiang, Michael D. Green, Xueting Lang, et al.. (2019). Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy. Cancer Research. 79(15). 3940–3951. 150 indexed citations

13.

Green, Michael D., et al.. (2017). Positive Externalities and the Economics of Proximate Cause. Washington and Lee law review. 74(3). 1517.

14.

Green, Michael D. & Hans‐Willem Snoeck. (2011). Novel approaches for immune reconstitution and adaptive immune modeling with human pluripotent stem cells. BMC Medicine. 9(1). 51–51. 7 indexed citations

15.

Green, Michael D., et al.. (2009). Rapid colorimetric field test to determine levels of deltamethrin on PermaNet^® surfaces: association with mosquito bioactivity. Tropical Medicine & International Health. 14(4). 381–388. 22 indexed citations

16.

Nyadong, Leonard, et al.. (2008). Desorption electrospray ionization reactions between host crown ethers and the influenza neuraminidase inhibitor oseltamivir for the rapid screening of Tamiflu®. The Analyst. 133(11). 1513–1513. 35 indexed citations

17.

Green, Michael D.. (2004). The Future of Proportional Liability. SSRN Electronic Journal. 2 indexed citations

18.

Green, Michael D., Thomas V. Cacciarelli, George Mazariegos, et al.. (1998). SERIAL MEASUREMENT OF EPSTEIN-BARR VIRAL LOAD IN PERIPHERAL BLOOD IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS DURING TREATMENT FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE1. Transplantation. 66(12). 1641–1644. 131 indexed citations

19.

Bickett, D. Mark, et al.. (1994). A High Throughput Fluorogenic Substrate for Stromelysin (MMP‐3). Annals of the New York Academy of Sciences. 732(1). 351–355. 12 indexed citations

20.

Green, Michael D.. (1984). From Here to Attorney’s Fees: Certainty Efficiency and Fairness in the Journey to the Appellate Courts. Cornell law review/The Cornell law quarterly. 69(2). 207–301.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact